Cite
HARVARD Citation
Takagi, M. et al. (2022). First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors. Cancer. 128 (15), pp. 2949-2957. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Takagi, M. et al. (2022). First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors. Cancer. 128 (15), pp. 2949-2957. [Online].